Tretten

Indicated For

congenital Factor XIII A-subunit deficiency

About This Medication

# Patient Assistance Program Application for Rare Blood Disorders Patient Guide: How to Get Tretten (catridecacog) at Low or No Cost Tretten (catridecacog) is a recombinant coagulation **factor XIII A-subunit**, used to prevent bleeding episodes in patients with congenital **factor XIII A-subunit deficiency**, a rare blood disorder. Novo Nordisk's **Patient Assistance Program (PAP)** provides this medication **at no charge** to eligible uninsured patients with low household income, helping those who cannot afford treatment.[1][3][10] ## About Tretten and Why Assistance Matters **Tretten** replaces the missing or defective factor XIII in your blood, which is essential for proper clotting and preventing spontaneous bleeds. Without it, patients risk life-threatening hemorrhages, including brain bleeds. This lifelong therapy is expensive, often costing tens of thousands annually, making PAP crucial for access.[3] Novo Nordisk's PAP targets **rare blood disorders** like factor XIII deficiency. It's free—no enrollment fees—and delivers a **90-day supply** of Tretten upon approval, renewable annually with income verification.[1][5] ## Who Qualifies? Eligibility focuses on residency, insurance status, and income: - **US citizen or legal resident** with a valid Social Security Number.[4][5][8] - **Uninsured**: No private prescription coverage (HMO/PPO), Medicare Part D (with exceptions noted below), Medicaid, VA benefits, or other federal/state programs.[3][4][8][10] - **Household income at or below 300%-400% of Federal Poverty Level (FPL)**, varying by program document—confirm current guidelines via 1-844-NOVOSEC.[4][8] - Prescribed Tretten for an indicated condition by a licensed provider.[3][8] **Exceptions**: - Medicare Part D patients: Eligible if spent $1,000 out-of-pocket this year (some sources say no $1,000 requirement—verify).[2][4][9] - Medicaid-eligible: Must submit denial letter.[4][8] - Medicare LIS applicants: Need denial.[4][8] ## Income Eligibility Breakdown Income must meet **FPL thresholds** based on household size. Use 400% FPL as conservative estimate (adjust per latest from Families USA).[4][8] Here's a table for 2026 (approximate; check HHS.gov for exact): | Household Size | 300% FPL | 400% FPL | |---------------|----------|----------| | 1 | $45,180 | $60,240 | | 2 | $61,320 | $81,760 | | 3 | $77,460 | $103,280| | 4 | $93,600 | $124,800| | +1 person | +$16,140| +$21,520| *Notes*: Include all income sources. Provide proof annually.[1][4][5] ## Insurance Requirements **Primarily for uninsured**. Cannot have active coverage. Submit denials for: - Medicaid/VA.[4][8] - Medicare Extra Help/LIS.[2][4] - No reimbursement from government programs if approved.[1][5] **Co-pay program alternative** for commercially insured: Up to $12,000-$15,000/year.[3] ## Step-by-Step Application Process **Multiple methods**: Online, download PDF, phone (1-844-NOVOSEC or 1-866-310-7549).[1][2][3] 1. **Discuss with HCP**: Get prescription for Tretten (90-day supply). HCP starts/completes sections.[1][5][9] 2. **Fill Application**: Patient/HCP complete patient info, prescriber section, certification. Sign/date.[1][4][8] 3. **Gather Documents**: - Proof of income: Tax return (1040), W-2/1099, SSA-1099, unemployment stmt, pension/interest.[4][5][8] - Denials: Medicaid, LIS, VA (if applicable).[4][8] - Govt ID, Medicare OOP proof ($1,000 if req'd).[2][4] 4. **Submit**: - **Online**: novocare.com/pap.html—HCP gets secure link, patient uploads docs.[2][9] - **Download/Mail**: novoMEDLINK or NovoCare PDFs to PO Box 18648, F PO Box.[1][5] - **Fax**: 1-888-868-9853 or (866)441-4190.[5][7] 5. **HCP Signs**: Prescription + product request form.[5][8] Opt for SMS/phone alerts.[1][2] ## Timeline and Delivery - **Processing**: 2 business days if complete; delays for incompletes. Mail adds 7 days.[1][2][5][9] - **Approval Notice**: Letter, phone/text if opted in.[1][2] - **Delivery**: 10-14 business days (up to 21) to **HCP office** or home via Neovance Pharmacy (call 1-800-488-5908).[1][9] - **Enrollment**: Rolling 12 months; reapply for refills (income annual).[5] ## Alternatives if Denied - **Appeal**: Contact program; complete missing info.[5] - **Co-pay Assistance**: If commercially insured, up to $15,000/year for Tretten.[3] - **Other Resources**: RxHope, RxAssist, NeedyMeds, state programs, or generic factors (none listed).[7][10] - **Biosimilars**: None available.[10] - Reapply after changes (e.g., insurance gap).[3] ## Refill Process New form per request, but income yearly. HCP/patient resubmit; 90-day supply.[5] ## Disclaimer This guide synthesizes public sources as of 2026; **program details change**. Verify eligibility/docs via Novo Nordisk (1-844-NOVOSEC). Not medical/financial advice—consult HCP/financial advisor. Novo reserves right to modify/cancel. No guarantee of approval; subject to availability.[1][5] *Word count: ~950*

Program information last verified: March 30, 2026